America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on June 9, 2026

Jun. 9, 2026

Bitget Launches Anti-Scam Month 2026, Recovers $32.3 Million for Users

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget lanza el Mes Antiestafas 2026 y ayuda a recuperar 32,3 millones de dólares para los usuarios

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget lance le Mois de la lutte contre la fraude 2026 et annonce avoir récupéré 32,3 millions de dollars pour ses utilisateurs

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget משיקה את חודש המלחמה בהונאות 2026, מחזירה 32.3 מיליון דולר עבור משתמשים

Indeterminate GlobeNewswire

Jun. 9, 2026

ビットゲット、「2026年アンチ・スキャム・マンス」をローンチ、ユーザーのために3,230万ドル (約52億円) を回収

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget, ‘Anti-Scam Month 2026’ 캠페인 개시하며 이용자 자산 3,230만 달러 회수 지원

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget Melancarkan Bulan Anti-Penipuan 2026, Memulihkan USD32.3 Juta untuk Pengguna

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget Lança Mês Anti-Scam 2026, Recupera US$ 32,3 Milhões para Usuários

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget 启动 2026 年反诈骗月，为用户追回 3,230 万美元

Indeterminate GlobeNewswire

Jun. 9, 2026

Bitget 啟動 2026 年反詐騙月，為用戶追回 3,230 萬美元

Indeterminate GlobeNewswire

Jun. 9, 2026

AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

Indeterminate GlobeNewswire

Jun. 9, 2026

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

Indeterminate GlobeNewswire

Jun. 9, 2026

Jet.AI Announces Review of Strategic Alternatives for SpaceX Equity Interest

Indeterminate GlobeNewswire

Jun. 9, 2026

Sensor Bio Welcomes Dr. Michael Poku as Clinical Advisor

Indeterminate EIN Presswire

Jun. 9, 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Indeterminate GlobeNewswire

Jun. 9, 2026

Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program

Indeterminate GlobeNewswire

Jun. 9, 2026

Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 

Indeterminate GlobeNewswire

Jun. 9, 2026

Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378

Indeterminate GlobeNewswire

Jun. 9, 2026

Vaxart to Participate in BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

GoldHaven Closes Upsized C$5.75 Million LIFE Financing to Advance Magno and Copeçal Projects

Indeterminate GlobeNewswire